Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of Antiretroviral Therapy on the Survival of Human Immunodeficiency Virus-positive Adult Patients in Andhra Pradesh, India: A Retrospective Cohort Study, 2007-2013

  • Received : 2016.07.21
  • Accepted : 2016.10.28
  • Published : 2016.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The survival outcomes of antiretroviral treatment (ART) programs have not been systematically evaluated at the state level in India. This retrospective study assessed the survival rates and factors associated with survival among adult human immunodeficiency virus (HIV)-infected patients in Andhra Pradesh, India. Methods: The present study used data from 139 679 HIV patients aged ${\geq}15$ years on ART who were registered from 2007 to 2011 and were followed up through December 2013. The primary end point was death of the patient. Mortality densities (per 1000 person-years) were calculated. Kaplan-Meier and Cox-regression models were used to estimate survival and explore the factors associated with survival. Results: The overall median follow-up time was 16.0 months (2.0 months for the deceased and 14.0 months for those lost to follow-up). Approximately 13.2% of those newly initiated on ART died during follow-up. Of those deaths, 56% occurred in the first three months. The crude mortality rate was 80.9 per 1000 person-years at risk. The CD4 count (adjusted hazard ratio [aHR],4.88; 95% confidence interval [CI], 4.36 to 5.46 for < $100cells/mm^3$ vs. > $350cells/mm^3$), functional status (aHR, 3.05; 95% CI, 2.82 to 3.30 for bedridden vs. normal), and body weight (aHR, 3.69; 95% CI, 3.42 to 3.97 for <45 kg vs. >60 kg) were strongly associated with the survival of HIV patients. Conclusions: The study findings revealed that high mortality was observed within the first three months of ART initiation. Patients with poor baseline clinical characteristics had a higher risk of mortality. Expanded testing and counseling should be encouraged, with the goal of ensuring early enrollment into the program followed by the initiation of ART in HIV-infected patients.

Keywords

References

  1. Joint United Nations Programme on HIV/AIDS. UNAIDS world AIDS day report 2012 [cited 2016 Nov 10]. Available from: http://www.unaids.org/sites/default/files/media_asset/JC2434_WorldAIDSday_results_en_1.pdf.
  2. National Institute of Medical Statistics; National AIDS Control Organization. Technical report: India HIV estimates-2012 [cited 2016 Nov 9]. Available from: http://files.unaids.org/en/media/unaids/contentassets/documents/data-and-analysis/tools/spectrum/India2012report.pdf.
  3. Bhatta L, Klouman E, Deuba K, Shrestha R, Karki DK, Ekstrom AM, et al. Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in Far-western region, 2006-2011. BMC Infect Dis 2013;13:604. https://doi.org/10.1186/1471-2334-13-604
  4. Mojumdar K, Vajpayee M, Chauhan NK, Mendiratta S. Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian population. BMC Public Health 2010;10:416. https://doi.org/10.1186/1471-2458-10-416
  5. Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002;360(9327):119-129. https://doi.org/10.1016/S0140-6736(02)09411-4
  6. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998;352 (9142):1725-1730. https://doi.org/10.1016/S0140-6736(98)03201-2
  7. World Health Organization. '3 by 5' Progress report: December 2003 through June 2004 [cited 2016 Nov 23]. Available from: http://www.who.int/3by5/en/Progressreport.pdf.
  8. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS 2011 World AIDS Day report [cited 2016 Nov 23]. Available from: http://www.unaids.org/en/resources/documents/ 2011/20111121_JC2216_WorldAIDSday_report_2011.
  9. National AIDS Control Organisation. Annual report 2015-16 [cited 2016 Nov 23]. Available from: http://naco.gov.in/sites/default/files/Annual%20Report%202015-16_NACO.pdf.
  10. Vella S, Schwartländer B, Sow SP, Eholie SP, Murphy RL. The history of antiretroviral therapy and of its implementation in resource-limited areas of the world. AIDS 2012;26(10):1231-1241. https://doi.org/10.1097/QAD.0b013e32835521a3
  11. World Health Organization. Antiretroviral therapy (ART) coverage among all age groups [cited 2016 Oct 22]. Available from: http://www.who.int/gho/hiv/epidemic_response/ART_text/en/.
  12. Chakravarty J, Tiwary NK, Prasad SR, Shukla S, Tiwari A, Mishra RN, et al. Determinants of survival in adult HIV patients on antiretroviral therapy in Eastern Uttar Pradesh: a prospective study. Indian J Med Res 2014;140(4):491-500.
  13. Rai S, Mahapatra B, Sircar S, Raj PY, Venkatesh S, Shaukat M, et al. Adherence to antiretroviral therapy and its effect on survival of HIV-infected individuals in Jharkhand, India. PLoS One 2013;8(6):e66860. https://doi.org/10.1371/journal.pone.0066860
  14. Ryavanki SP, Kosambiya JK, Mehta A, Dayama S, Solanki N, Kantharia SL. General profile and survival probabilities of HIV patients registered at anti retroviral therapy (ART) centre, New Civil Hospital, Surat, Gujarat. Natl J Community Med 2013; 4(2)201-207.
  15. Bachani D, Garg R, Rewari BB, Hegg L, Rajasekaran S, Deshpande A, et al. Two-year treatment outcomes of patients enrolled in India's national first-line antiretroviral therapy programme. Natl Med J India 2010;23(1):7-12.
  16. Department of AIDS Control, Ministry of Health and Family Welfare. Annual report: 2013-14 [cited 2016 Nov 9]. Available from: http://naco.gov.in/sites/default/files/NACO_English% 202013-14.pdf.
  17. Department of AIDS Control, Ministry of Health and Family Welfare. Annual report: 2008-2009 [cited 2016 Nov 9]. Available from: http://naco.gov.in/sites/default/files/Annual_Report_NACO_2008-09.pdf.
  18. National AIDS Control Organization. Antiretroviral therapy guidelines for HIV-infected adults and adolescents including post-exposure prophylaxis; 2007 [cited 2016 Nov 9]. Available from: http://apps.who.int/medicinedocs/documents/s18021 en/s18021en.pdf.
  19. Mishra BN, Sinha ND, Shukla SK, Das RN. The epidemiology of opportunistic infections in HIV/AIDS cases in Nepal. Indian J Prev Soc Med 2009;40(1-2):96-100.
  20. Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2011;53(11): 1130-1139. https://doi.org/10.1093/cid/cir626
  21. Alemu AW, Sebastian MS. Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia. Glob Health Action 2010;3:5398. https://doi.org/10.3402/gha.v3i0.5398
  22. Deuba K, Ekstrom AM, Shrestha R, Ionita G, Bhatta L, Karki DK. Psychosocial health problems associated with increased HIV risk behavior among men who have sex with men in Nepal: a cross-sectional survey. PLoS One 2013;8(3):e58099. https://doi.org/10.1371/journal.pone.0058099
  23. Jerene D, Endale A, Hailu Y, Lindtjorn B. Predictors of early death in a cohort of Ethiopian patients treated with HAART. BMC Infect Dis 2006;6:136. https://doi.org/10.1186/1471-2334-6-136
  24. Mageda K, Leyna GH, Mmbaga EJ. High initial HIV/AIDS-related mortality and -its predictors among patients on antiretroviral therapy in the Kagera region of Tanzania: a five-year retrospective cohort study. AIDS Res Treat 2012;2012:843598.
  25. Sieleunou I, Souleymanou M, Schönenberger AM, Menten J, Boelaert M. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health 2009;14(1):36-43. https://doi.org/10.1111/j.1365-3156.2008.02183.x
  26. Bajpai RC, Raj PY, Jha UM, Chaturvedi HK, Pandey A. Demographic correlates of survival in adult HIV patients registered at ART centers in Andhra Pradesh, India: a retrospective cohort study. Public Health Res 2014;4(1):31-38.
  27. Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI, Aglen HE, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis 2008;8:52. https://doi.org/10.1186/1471-2334-8-52
  28. Alibhai A, Kipp W, Saunders LD, Senthilselvan A, Kaler A, Houston S, et al. Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda. Int J Womens Health 2010;2:45-52.
  29. Shafique N. Preventing mother-to-child HIV transmission through community-based approach in Nepal. In: International AIDS Society. Proceedings of AIDS 2012: XIX International AIDS Conference; 2012 Jul 22-27; Washington, DC, USA. Geneva: International AIDS Society; 2012.
  30. Centers for Disease Control and Prevention. Latent tuberculosis infection: a guide for primary health care providers [cited 2016 Oct 22]. Available from: http://www.cdc.gov/tb/publications/ltbi/.
  31. Biadgilign S, Reda AA, Digaffe T. Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study. AIDS Res Ther 2012;9 (1):15. https://doi.org/10.1186/1742-6405-9-15
  32. Kee MK, Lee JH, Kim EJ, Lee J, Nam JG, Yoo BH, et al. Improvement in survival among HIV-infected individuals in the Republic of Korea: need for an early HIV diagnosis. BMC Infect Dis 2009;9:128. https://doi.org/10.1186/1471-2334-9-128
  33. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 2009;4(6):e5790. https://doi.org/10.1371/journal.pone.0005790

Cited by

  1. How varying CD4 criteria for treatment initiation was associated with mortality of HIV-patients? A retrospective analysis of electronic health records from Andhra Pradesh, India vol.10, pp.1, 2016, https://doi.org/10.7189/jogh.10.010408
  2. Rate and Predictors of Mortality Among Adults on Antiretroviral Therapy at Debre Markos Referral Hospital, North West Ethiopia vol.13, pp.None, 2016, https://doi.org/10.2147/hiv.s294111
  3. Predictors of Mortality Among Adult HIV-Infected Patients Taking Antiretroviral Therapy (ART) in Harari Hospitals, Ethiopia vol.13, pp.None, 2016, https://doi.org/10.2147/hiv.s309018